Evidence map›Paper›PMID 38203854›Full record

ArticleInternational journal of molecular sciences2024

Secretome Analyses Identify FKBP4 as a

Rika Kojima, Wojciech Paslawski, Guochang Lyu, Ernest Arenas, Xiaoqun Zhang, Per Svenningsson

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.9field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Thioredoxin Domain Containing 5 (TXNDC5): Friend or Foe?Current issues in molecular biology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Rika KojimaDepartment of Clinical Neuroscience, Karolinska Institutet, 171 76 Stockholm, Sweden.ORCID 0000-0002-2745-960X
Wojciech PaslawskiDepartment of Clinical Neuroscience, Karolinska Institutet, 171 76 Stockholm, Sweden.ORCID 0000-0003-2141-4547
Guochang LyuDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 77 Stockholm, Sweden.
Ernest ArenasDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 77 Stockholm, Sweden.ORCID 0000-0003-0197-6577
Xiaoqun ZhangDepartment of Clinical Neuroscience, Karolinska Institutet, 171 76 Stockholm, Sweden.
Per SvenningssonDepartment of Clinical Neuroscience, Karolinska Institutet, 171 76 Stockholm, Sweden.ORCID 0000-0001-6727-3802
Karolinska Institutet · SE

Funding

European Research Council 649116European Research Council 884608
6 · The paper itself

Abstract

Mutations in the

Indexed as

Induced Pluripotent Stem CellsParkinson DiseaseTacrolimus Binding ProteinsCerebrospinal Fluid ProteinsHumansMembrane ProteinsMutationNerve Tissue ProteinsProtein Disulfide-IsomerasesSecretomeCerebrospinal Fluid ProteinsMembrane ProteinsNerve Tissue ProteinsProtein Disulfide-IsomerasesSEMA3F protein, humantacrolimus binding protein 4Tacrolimus Binding ProteinsTXNDC5 protein, humancerebrospinal fluidFKBP4GBA1human-induced pluripotent stem cells (hiPSCs)Parkinson’s diseasesecretome

Identifiers

PMID38203854
PMCPMC10779269
OpenAlexW4390614300

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.